ATORVASTATIN VS ROSUVASTATIN; FENOFIBRATE AS AN ADD ON: AN EXPLORATORY STUDY

Abstract

Objective: Statins being the first choice drug for dyslipidaemia, the quest for better one among all has always been and still a question for research in the field of medicine. Objective­ The objective of our study was to find out the best statin among the two, Atorvastatin and Rosuvastatin, in terms of efficacy and safety; alone or in combination with Fenofibrate for the management of dyslipidaemia.Methods: This was an open label, randomized, parallel group, prospective comparative study, carried out in patients in two groups treated with Atorvastatin and Rosuvastatin (10mg each) for 6 weeks, after which Fenofibrate (67mg) was added as an add on therapy in either group for the next 4 weeks before and after treatment.Results: After the treatment, the TC, TG, LDL- C, HDL- C and Non HDL- C were comparable between two groups. The changes in the levels of TC were -15.90±5.16 (-8.53%) vs -20.70±4.83 (-11.32%) respectively in groups treated with Atorvastatin (group I) and Rosuvastatin (group II). Changes in TGs were -11.60±4.16 (-7.46%) vs -15.10±5.18 (-9.99%), respectively; change in LDL- C were -16.90±3.58 (-15.31%) vs -13.0±3.04 (-11.56%) respectively; change in HDL- C were +6.75±0.86 (+18.72%) vs +9.0±1.22 (+23.72%) respectively in each group; change in Non HDL- C were found to be -6.90±4.83 (-4.4%) vs -7.8±4.78 (-5.05%) respectively in groups I and II. After the addition of Fenofibrate (67mg) there were no significant changes in the different parameters of serum lipid profile.Conclusion: The result of our study suggests that Rosuvastatin (10mg) was more efficacious than Atorvastatin (10mg) in lipid lowering effect and HDL- C raising effect but should be used with great caution and care in patients with uncontrolled hyperglycaemia and in those with compromised hepatic status. Further addition of Fenofibrate (67mg) didn’t make any significant difference in the result. 

Authors and Affiliations

Mohammad Arif Khan, Krishna Murti, Vaibhav Grover, Kanhaya Lal, Dharmendra Singh, Pradeep Das

Keywords

Related Articles

ANTIMYCOBACTERIAL, ANTIMICROBIAL AND ANTIFUNGAL ACTIVITIES OF GERANIUM OIL-LOADED NANO CAPSULES

Objective: The aim of this study was to perform the first ever investigation of the effect of activities in the nano capsules containing Geranium oil (NC1) against different species of pathogens such as Mycobacterium...

ELECTRONIC ABSORPTION SPECTRA OF SOME PHOTOSENSITIZERS BEARING CARBOXYLIC ACID GROUPS: INSIGHTS FROM THEORY

Objective: The main objective of this research work was to give insight from theory in interpreting electronic absorption spectra of tetrapyrrolic macrocycles bearing carboxylic acid groups: protoporphyrin IX, pheophorbi...

CANAL DISH (CD), THE NEW ANTIMICROBIAL TESTING APPARATUS

Objective: This writing aims to introduce new antimicrobial test apparatus called Canal Dish (CD), theoretically.Methods: We have designed two types of CD such as Circular CD (CCD) and Square CD (SCD). Internally, the CC...

NATURAL IRON SEQUESTERING AGENTS: THEIR ROLES IN NATURE AND THERAPEUTIC POTENTIAL

Iron is one of the essential elements involved in many cellular processes that are necessary for life, including oxygen sensing, oxygen transport, electron transfer, energy metabolism, DNA synthesis etc. Although, iron i...

SUCCINIMIDES: SYNTHESIS, REACTION AND BIOLOGICAL ACTIVITY

This review summarizes the synthetic methods, reactions and biological application of important pharmacological succinimides and summarizes recent developments in their derivatives such as dichlorodiformyl, Schiff base,...

Download PDF file
  • EP ID EP579760
  • DOI -
  • Views 96
  • Downloads 0

How To Cite

Mohammad Arif Khan, Krishna Murti, Vaibhav Grover, Kanhaya Lal, Dharmendra Singh, Pradeep Das (2014). ATORVASTATIN VS ROSUVASTATIN; FENOFIBRATE AS AN ADD ON: AN EXPLORATORY STUDY. International Journal of Pharmacy and Pharmaceutical Sciences, 6(8), 493-498. https://europub.co.uk/articles/-A-579760